1 |
Jakubowska MA, Kerkhofs M, Martines C, Efremov DG, Gerasimenko JV, Gerasimenko OV, Petersen OH, Bultynck G, Vervliet T, Ferdek PE. ABT-199 (Venetoclax), a BH3-mimetic Bcl-2 inhibitor, does not cause Ca2+ -signalling dysregulation or toxicity in pancreatic acinar cells. Br J Pharmacol 2019;176:4402-15. [PMID: 30266036 DOI: 10.1111/bph.14505] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
2 |
Kerkhofs M, Bittremieux M, Morciano G, Giorgi C, Pinton P, Parys JB, Bultynck G. Emerging molecular mechanisms in chemotherapy: Ca2+ signaling at the mitochondria-associated endoplasmic reticulum membranes. Cell Death Dis 2018;9:334. [PMID: 29491433 DOI: 10.1038/s41419-017-0179-0] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 13.8] [Reference Citation Analysis]
|
3 |
Erekat NS. Apoptosis and its therapeutic implications in neurodegenerative diseases. Clin Anat 2022;35:65-78. [PMID: 34558138 DOI: 10.1002/ca.23792] [Reference Citation Analysis]
|
4 |
Chen C, Lin W, Wong K, Cheng K, Leung Y, Yang S. Gossypol stimulates opening of a Ca 2+ - and Na + -permeable but Ni 2+ - and Co 2+ -impermeable pore in bEND.3 endothelial cells. Clin Exp Pharmacol Physiol 2018;45:788-96. [DOI: 10.1111/1440-1681.12929] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|